Skip to content

Seres Therapeutics, Inc.

MCRB · XNAS

CIK 1609809fmd_1N3RTF70SV8EPT2Q4WGTAEPB6BManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2013 to Sep 30, 2026, 52 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading